What determines patient preferences for treating low risk basal cell carcinoma when comparing surgery vs imiquimod?: a discrete choice experiment survey from the SINS trial
Background: The SINS trial (Controlled Clinical Trials ISRCTN48755084; Eudract No. 2004-004506-24) is a randomised controlled trial evaluating long term success of excisional surgery vs. imiquimod 5% cream for low risk nodular and superficial basal cell carcinoma (BCC). The trial included a discre...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BioMed Central
2012
|
Online Access: | http://eprints.nottingham.ac.uk/2903/ http://eprints.nottingham.ac.uk/2903/ http://eprints.nottingham.ac.uk/2903/ http://eprints.nottingham.ac.uk/2903/1/PrefsurveyOzolins.pdf |